XML 15 R6.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($)
$ in Millions
Total
Total Dentsply Sirona Equity
Common Stock
Capital in Excess of Par Value
Retained Earnings
Accumulated Other Comprehensive Loss
Treasury Stock
Noncontrolling Interests
Beginning Balance at Dec. 31, 2020 $ 4,935.0 $ 4,932.0 $ 3.0 $ 6,604.0 $ 1,198.0 $ (464.0) $ (2,409.0) $ 3.0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 112.0 112.0     112.0      
Other comprehensive loss (90.0) (90.0)       (90.0)    
Exercise of stock options 33.0 33.0   11.0     22.0  
Stock based compensation expense 13.0 13.0   13.0        
Funding of employee stock purchase plan 3.0 3.0   1.0     2.0  
Treasury shares purchased (90.0) (90.0)   0.0     (90.0)  
Restricted stock unit distributions (4.0) (4.0)   (11.0)     7.0  
Cash dividends (22.0) (22.0)     (22.0)      
Ending Balance at Mar. 31, 2021 4,890.0 4,887.0 3.0 6,618.0 1,288.0 (554.0) (2,468.0) 3.0
Beginning Balance at Dec. 31, 2020 4,935.0 4,932.0 3.0 6,604.0 1,198.0 (464.0) (2,409.0) 3.0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 208.0              
Other comprehensive loss (47.0)              
Ending Balance at Jun. 30, 2021 5,034.0 5,031.0 3.0 6,638.0 1,359.0 (511.0) (2,458.0) 3.0
Beginning Balance at Mar. 31, 2021 4,890.0 4,887.0 3.0 6,618.0 1,288.0 (554.0) (2,468.0) 3.0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 96.0 96.0     96.0     0.0
Other comprehensive loss 43.0 43.0       43.0    
Exercise of stock options 12.0 12.0   3.0     9.0  
Stock based compensation expense 19.0 19.0   19.0        
Restricted stock unit distributions (1.0) (1.0)   (2.0)     1.0  
Cash dividends (25.0) (25.0)     (25.0)      
Ending Balance at Jun. 30, 2021 5,034.0 5,031.0 3.0 6,638.0 1,359.0 (511.0) (2,458.0) 3.0
Beginning Balance at Dec. 31, 2021 4,997.0 4,996.0 3.0 6,606.0 1,514.0 (592.0) (2,535.0) 1.0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 69.0 69.0     69.0      
Other comprehensive loss (37.0) (37.0)       (37.0)    
Exercise of stock options 5.0 5.0   1.0     4.0  
Stock based compensation expense 11.0 11.0   11.0        
Funding of employee stock purchase plan 2.0 2.0   1.0     1.0  
Accelerated share repurchase (150.0) (150.0)   (30.0)     (120.0)  
Restricted stock unit distributions (6.0) (6.0)   (16.0)     10.0  
Cash dividends (27.0) (27.0)     (27.0)      
Ending Balance at Mar. 31, 2022 4,864.0 4,863.0 3.0 6,573.0 1,556.0 (629.0) (2,640.0) 1.0
Beginning Balance at Dec. 31, 2021 4,997.0 4,996.0 3.0 6,606.0 1,514.0 (592.0) (2,535.0) 1.0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 142.0              
Other comprehensive loss (127.0)              
Ending Balance at Jun. 30, 2022 4,838.0 4,837.0 3.0 6,617.0 1,602.0 (719.0) (2,666.0) 1.0
Beginning Balance at Mar. 31, 2022 4,864.0 4,863.0 3.0 6,573.0 1,556.0 (629.0) (2,640.0) 1.0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 73.0 73.0     73.0      
Other comprehensive loss (90.0) (90.0)       (90.0)    
Exercise of stock options 2.0 2.0   0.0     2.0  
Stock based compensation expense 16.0 16.0   16.0        
Funding of employee stock purchase plan 1.0 1.0         1.0  
Accelerated share repurchase 0.0     30.0     (30.0)  
Restricted stock unit distributions (2.0) (2.0)   (3.0)     1.0  
Restricted stock unit dividends 0.0     1.0 (1.0)      
Cash dividends (26.0) (26.0)     (26.0)      
Ending Balance at Jun. 30, 2022 $ 4,838.0 $ 4,837.0 $ 3.0 $ 6,617.0 $ 1,602.0 $ (719.0) $ (2,666.0) $ 1.0